Acadia Pharmaceuticals
ACAD
ACAD
256 hedge funds and large institutions have $2.4B invested in Acadia Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 90 increasing their positions, 81 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
8% less capital invested
Capital invested by funds: $2.62B → $2.4B (-$214M)
17% less first-time investments, than exits
New positions opened: 35 | Existing positions closed: 42
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
Holders
256
Holding in Top 10
3
Calls
$16M
Puts
$6.39M
Top Buyers
| 1 | +$18.7M | |
| 2 | +$14.2M | |
| 3 | +$11.8M | |
| 4 |
Two Sigma Investments
New York
|
+$11.7M |
| 5 |
ITP
Iron Triangle Partners
Cos Cob,
Connecticut
|
+$11.5M |
Top Sellers
| 1 | -$60.3M | |
| 2 | -$34.9M | |
| 3 | -$24.4M | |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
-$21.9M |
| 5 |
JAM
Jupiter Asset Management
London,
United Kingdom
|
-$13.9M |